Search

Search Constraints

You searched for: Subject 615.37

Search Results

73. A Novel CD3/BCMA Bispecific T-cell Redirecting Antibody for the Treatment of Multiple Myeloma. Issue 2 (27th February 2022)

74. A Novel CD3/BCMA Bispecific T-cell Redirecting Antibody for the Treatment of Multiple Myeloma. Issue 2 (February 2022)

76. A Novel Fc-Engineered Anti-HER2 Bispecific Antibody With Enhanced Antitumor Activity. Issue 4 (20th May 2023)